Progyny, Inc. Capital Expenditures

Capital Expenditures of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capital Expenditures growth rates and interactive chart. Capital expenditures, commonly known as Capex, are funds used by a company to acquire, upgrade, and maintain physical or intangible assets such as property, buildings, an industrial plant, technology, software or equipment. Capex is often used to undertake new projects or investments by the firm. A company must invest over its lifetime into productive assets to maintain its competitiveness and ensure its survival.


Highlights and Quick Summary

  • Capital Expenditures for the quarter ending June 29, 2021 was $-430 Thousand (a 16.53% increase compared to previous quarter)
  • Year-over-year quarterly Capital Expenditures increased by 188.59%
  • Annual Capital Expenditures for 2020 was $-1.04 Million (a -64.92% decrease from previous year)
  • Annual Capital Expenditures for 2019 was $-2.96 Million (a 410.54% increase from previous year)
  • Annual Capital Expenditures for 2018 was $-579 Thousand (a -5.39% decrease from previous year)
  • Twelve month Capital Expenditures ending June 29, 2021 was $-1.05 Million (a 46.56% increase compared to previous quarter)
  • Twelve month trailing Capital Expenditures decreased by -67.53% year-over-year
Trailing Capital Expenditures for the last four month:
29 Jun '21 30 Mar '21 30 Dec '20 29 Sep '20
$-1.05 Million $-713 Thousand $-1.04 Million $-3.22 Million
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capital Expenditures of Progyny, Inc.

Most recent Capital Expendituresof PGNY including historical data for past 10 years.

Interactive Chart of Capital Expenditures of Progyny, Inc.

Progyny, Inc. Capital Expenditures for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $-0.43 $-0.37
2020 $-0.1 $-0.15 $-0.1 $-0.69 $-1.04
2019 $-2.28 $-0.42 $-0.13 $-0.13 $-2.96
2018 $-0.18 $-0.04 $-0.37 $-0.58
2017 $-0.61 $-0.61

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.